• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number TFGT-23A
Device Problem Incomplete Coaptation (2507)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/21/2023
Event Type  malfunction  
Event Description
It was reported that on (b)(6) 2023, a 23mm trifecta gt was selected for an implant.Once the trifecta valve was implanted, the physician spread normal saline on the trifecta valve for function test, and found it was not working.For safety, the physician explanted the trifecta valve and exchanged to non-abbott device.Patient is well treated and stable.
 
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that on (b)(6) 2023, a 23mm trifecta gt was selected for an implant.Once the trifecta valve was implanted, the physician spread normal saline on the trifecta valve for function test, and found it was not working.For safety, the physician explanted the trifecta valve and exchanged to non-abbott device.Patient is well treated and stable.
 
Manufacturer Narrative
The reported event of valve cannot coapt well could not be confirmed.No anomalies were found with the valve cusps, and functional testing at the time of manufacturing and upon return to abbott indicated the valve functioned normally.This test ensures proper cuspal coaptation and hemodynamic performance.The free state of the leaflets, without physiological pressure applied, is not indicative of actual leaflet coaptation or valve function.Imaging from the field appeared to show the placement of the valve.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The cause of the reported event could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA¿ GT VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17725884
MDR Text Key323158008
Report Number2135147-2023-03943
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05415067018229
UDI-Public05415067018229
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/11/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberTFGT-23A
Device Lot Number7715145
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/01/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/20/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/07/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-